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A loss of skeletal muscle mass occurs in various catabolic
states such as cachexia, sarcopenia, and inactivity1. The prin-
cipal change in muscle mass is related to altered muscle pro-
tein turn-over rates (imbalance between protein synthesis and
degradation) for example shown following various periods of
inactivity or unloading2-5. Which of the two key mechanisms
of protein turnover, muscle protein synthesis (MPS) or muscle
protein breakdown (MPB) might be more critical in disuse pro-
tein wasting is still not known6-8.
Myofibrils comprise nearly 80% of skeletal muscle mass9
and it is therefore no surprise that atrophy is largely due to pro-
tein wasting. The ubiquitin-proteasome pathway (UPP) and the
calcium-activated calpain system are two key players in MPB.
The UPP accounts for global proteolysis in normal and diseased
muscle10 while activated calpains and their endogenous in-
hibitor calpastatin, are involved in the proteolysis of function-
ally relevant structural proteins such as the cytoskeletal
anchorage complexes11 and myofibrillar proteins12. Intact my-
ofibrils in a sarcomere are apparently “preprocessed” by the
calpain system, which seems to be critical for providing access
to the proteasome-mediated MPB13. The proteasome-dependent
proteolysis is activated or inactivated during skeletal muscle
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Abstract
Objectives: To investigate the effect of whey protein plus potassium bicarbonate supplement on disused skeletal muscle struc-
ture and proteolysis after bed rest (BR). Methods: Soleus (SOL) and vastus lateralis (VL) biopsies were sampled from ten (n=10)
healthy male subjects (aged 31±6 years) who did BR once with and once without protein supplement as a dietary countermeasure
(cross-over study design). The structural changes (myofibre size and type distribution) were analysed by histological sections,
and muscle protein breakdown indirectly via the proteolysis markers, calpain 1 and 3, calpastatin, MuRF1 and 2, both in muscle
homogenates and by immunohistochemistry. Results: BR caused size-changes in myofiber cross-sectional area (FCSA, SOL,
p=0,004; VL, p=0.03), and myofiber slow-to-fast type transition with increased hybrids (SOL, p=0.043; VL, p=0.037) however
with campaign differences in SOL (p<0.033). No significant effect of BR and supplement was found by any of the key proteolysis
markers. Conclusions: Campaign differences in structural muscle adaptation may be an issue in cross-over design BR studies.
The whey protein plus potassium bicarbonate supplement did not attenuate atrophy and fibre type transition during medium term
bed rest. Alkaline whey protein supplements may however be beneficial as adjuncts to exercise countermeasures in disuse.
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overload or disuse, respectively14. Elevated ubiquitinated mus-
cle proteins15 and E3 ligase muscle RING-finger protein-1
(MuRF1) mRNA were shown to be proxies for increased pro-
tein breakdown following bed rest16 or spaceflight17. Reliable
serological muscle loss biomarkers are still not available to
study dynamic muscle protein balance, for example, in human
disuse18. Proteolysis markers thus still provide an indirect indi-
cation of MPB in disused human skeletal muscle.
High protein intake and essential amino acid supplementa-
tion are generally considered safe and helpful tools to induce
anabolic cell signaling pathways to stimulate protein synthe-
sis19 in cachexia and sarcopenia20 but also showed anti-cata-
bolic effects on disused skeletal muscle following bed rest21-24.
More recently, supplementation of whey protein as nutrient
has been applied as an anti-catabolic regimen to overcome pro-
tein deficits or protein wasting in humans25,26. Rapidly di-
gestible and leucine rich whey protein supplements were
shown to enhance protein synthesis in human skeletal mus-
cle27-28. Nonetheless, a disadvantage of a high leucine protein
intake is the generation of acidic byproducts, i.e., sulphuric
acid from sulphur containing amino acids in whey proteins29.
As a consequence, whey supplementation potentially increases
the renal acid load, and thereby leads to low-grade metabolic
acidosis30 that, in turn, increases MPB31 that is a catabolic sig-
nal associated with muscle wasting32. The anabolic potential
of a whey protein supplementation may thus be optimized by
neutralizing this acidogenic effect by alkaline salts. In support
of this it has been found that supplementation with whey pro-
tein and potassium bicarbonate (K-base, KHCO3) maintained
lean tissue mass in older humans33. However it is presently un-
known whether such a combination has a therapeutic potential
to attenuate atrophy and alleviate muscle protein wasting in
disuse during bed rest. 
Here, we report the effect of 21 days medium-term 6° head
down-tilt bed rest (MTBR study) on structural, immunohisto-
chemical and biochemical properties of disused skeletal mus-
cle. This was investigated in a randomized cross-over
controlled head-down tilt bed rest (BR) study with ten (n=10)
healthy men34. 
Our main hypothesis was that whey protein plus KHCO3
supplementation (i) helps to maintain structural myofiber prop-
erties (size and type distribution), and (ii) attenuate muscle
protein breakdown detectable via skeletal muscle specific in-
direct proteolysis markers35-37 during BR.
Materials and methods
Bed rest study
The 21 days 6° head-down-tilt (HDT) medium-term bed rest
(MTBR/MEP-study) took place at the German Aerospace Cen-
ter (DLR) in Cologne, Germany. The first campaign was per-
formed in September and October 2011, and the second
campaign in February and March 2012. The study was spon-
sored by the European Space Agency (ESA) and performed in
accordance with the ESA bed rest standardization plan. The
study was a controlled and randomized classical cross-over de-
sign. Energy- and nutrient intake were recorded, nutrition was
controlled and standardised, and the intake of whey protein
isolate+KHCO3 prescribed as reported elsewhere
34. Ten (n=10)
voluntary healthy men (aged 23 to 43 years) were recruited
and selected after a strict psychological, physiological and
medical screening. Anthropometric data of the MTBR study
are given in Table 1 and can also be obtained elsewhere (see
www.clinical.trials.gov, Identifier: NCT01655979). Subjects
were assigned to two groups and studied twice in two follow-
up campaigns, once receiving a combination of whey protein
plus KHCO3 (K-base, bicarbonate) diet, and once receiving a
standardized isocaloric diet as countermeasure34. For the 1st
campaign, five of the participants (n=5) were randomly as-
signed to a bed rest-only control (CTR), and the other five par-
ticipants (n=5) were randomly assigned to a bed rest
intervention (NUTR) group. For the 2nd campaign (starting
after a 12 weeks wash-out phase after the 1st campaign), the
groups were assigned the other way around. In the 2nd cam-
paign, biopsies were sampled except from two subjects (one
had medical problems unrelated to the study and one withdrew
from the study resulting in ten biopsied participants (1st cam-
paign) and eight biopsied participants (2nd campaign)34. Peer
review and ethical approval of the study were given by the Eth-
ical Board of the Ärztekammer Nordrhein, Duesseldorf, Ger-
many (Medium-term whey protein [MEP] - bed rest study,
#2010426 from 13/05/2011). The study adhered to the Decla-
ration of Helsinki. Participants provided informed consent
after study information briefings and were allowed to with-
draw from the study at any moment.
Nutritional intervention
Nutritional intervention was a combination of whey protein
(WP) plus bicarbonate (WP + BC-only, no exercise) supple-
menting the daily food intake34. The whey protein isocalori-
cally replaced fat and carbohydrates. For the WP+BC group,
named NUTR group throughout this study, supplementation
of WP (0.6g · g-1 · body weight-1 · day-1) resulted in total pro-
tein intake of 1.8 g · kg-1 · body mass-1. WP was supplied by
Diaprotein® (Dr. Steudle Inc.). Protein powder was dissolved
in milk products. In addition to WP, the NUTR group also re-
Subjects (n=10) 1st campaign 2nd campaign*
Age (years) 31.6 ± 5 31.5 ± 5 
Height (m) 1.80 ± 0.06 1.80 ± 0.03 
Weight (kg) 76.1 ± 8 70.0 ± 6
BMI 23.43 ± 1 24.02 ± 2
Cross-over design: 1st campaign (n=10); *2nd campaign (n=8) drop-
out of one subject; BMI: Body Mass Index [kg · m-2]; for more details
see Buehlmeier J et al.,34.
Table 1. Anthropometric data of subjects of the MTBR study (mean
 +/- S.D.).
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ceived bicarbonate (BC, 6 x 15 mmol) in six portions within
meals and snacks to achieve daily supplementation of 90 mmol
KHCO3 · day-1 (Krueger GmbH). The CTR-group received a
standardized isocaloric diet to meet the basic nutrient recom-
mendations. Further details on the diet that adhered to the stan-
dardisation plan of the European Space Agency (ESA), for
example, subject-matched menus, matching energy intake to
expenditure as calculated by PRODI® 5.6 software, and vitamin
intake (recommended daily allowances), in particular Vitamin
D supplementation (1.000 IE) due to missing UVB light in the
bed rest facility, are described elsewhere34. Intake of caffeine,
methylxanthine and alcohol was prohibited during the study.
Muscle biopsy
Muscle biopsies were sampled two days before the start of
the bed rest period (preBR, BDC-2) and shortly before ream-
bulation (postBR, HDT19) from the lateral aspect of the
quadriceps femoris muscle (vastus lateralis [VL], phasic,
mixed fast/slow type), and from the deep calf soleus muscle
(SOL, postural, mostly slow-type) of the right leg. A Rongeur
forceps (Zepf Medizintechnik) was used for skeletal muscle
tissue sampling through an approx. 1 cm skin/fascia incision
following local anesthesia (2 ml of 1% Lidocain). In total, sev-
enty-two (n=72) individual biopsies were collected from either
muscles from the 1st campaign subjects (n=10) or from the 2nd
campaign subjects (n=8). The samples were subdivided into
one histology piece (i.e., longitudinally fibre orientation as-
sessed by optical stereoscopy) and several other tissue pieces
(approx. 20 mg each) for biochemical and molecular analysis.
The histology piece was embedded with O.C.T. compound
(Scigen® Gardena) for better longitudinal orientation. All sam-
ples were immediately frozen in liquid nitrogen, while vigor-
ously shaking, and stored at -80°C until further use.
Immunohistochemistry (IHC)
Serial 8 μm cross sections were cut in a cryotome at minus
20°C (CM 1860, LEICA Microsystems). The sections were
mounted on coded glass slides (SuperFrost® Plus, 631-0108,
VWR International) and incubated with one, two or three dif-
ferent primary antibodies. Primary antibodies used were anti-
myosin-heavy chain (M8421 recognizes slow MyHC I, clone
My32, M4276 recognizes fast IIa, IIb or IIx, Sigma), and
mono- or polyclonal antibodies for the subsarcolemmal protein
dystrophin (mono #107416, Novocastra, or poly SC-15376,
Santa Cruz Inc.) according to previously published protocols35.
The location of primary antigen binding was detected by flu-
orescent dye-conjugated secondary antibodies using red-fluo-
rescent (Alexa Fluor 555 labelled goat-anti-mouse, A21421,
and polyclonal goat-anti-rabbit, A21429, Invitrogen), -green
fluorescent (Alexa Fluor 488 labelled mouse monoclonal,
A11025, and polyclonal goat-anti-rabbit, A11034, Molecular
Probes), or blue fluorescent (Alexa Fluor 635, labelled,
A31575, goat anti-mouse, Molecular Probes). Fibre cross-sec-
tional area (FCSA) and myofibre type distribution (type I vs.
type II) were calculated/determined in groups of transversely
cut myofibre profiles outlined by dystrophin-immunopositive
sarcolemma membrane within the region-of-interest (ROI)
using LEICA built-in software. FCSA is given in square mi-
crons (μm2). Fibre type distribution was assessed by individ-
ually counting myofibres immunoreactive for MyHC type I,
MyHC type IIa, IIx or hybrid fibres (MyHC I/MyHC II co-im-
munoreactivity in myofibre profiles). All determinations were
done in triplicate according to statistical protocols as previ-
ously published36.  A minimum of 30 myofibres from each sub-
ject, muscle and BR condition were screened to determine the
proportions and CSA of each fibre type. Routine epifluores-
cence microscopy (ZEISS Axioplan) and/or high-resolution
three channel (HeNe [543 and 633 nm] and Argon [453 nm])
multilaser confocal analysis (TCS SP-2, LEICA) were used
for subject-matched semi-quantitative image analysis of im-
munohistochemistry. A pair-wise analysis of post vs. pre bed
rest cryosections from identical subjects immunostained in the
same incubation protocol was performed to avoid any bias be-
tween immunohistochemical protocols and to balance inter-
subject variability39.
Myosin heavy chain composition
The myosin heavy chain (MyHC) composition was deter-
mined as previously reported37. The separating and stacking
gel contained 30% glycerol and 7% and 4% polyacrylamide,
respectively. One 10 μm biopsy cryosection was dissolved in
100 μL sample buffer (Laemmli) of which 10 μL was loaded
onto the gel. The gel run for 27 h at 15οC and bands were vi-
sualized with the Silver Stain plus kit (Biorad), and identified
(type I, IIx and IIa) based on their migration distance. Quantity
OneTM (Biorad) was used to determine the relative proportion
of each of the MyHC isoforms, using the lane density profile.
Protein assays
Small amounts of muscle samples (approx. 3-5 mg wet
mass) from each subject and muscle were lysed 1:10 with
RIPA-buffer (50 mM TRIS, 150 mM NaCl, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS, 2 mM MgCl2, plus Com-
plete Mini with pepstatin and sodium fluorate, and benzoase,
pH 7.3-7.4). Total protein concentration in homogenates was
determined in supernatant by the colorimetric BCA-Protein
Assay (Pierce Inc.) and presented as mg · ml-1· g wet mass-1
for each sample.
Protein biochemistry and Western Blotting (WB)
Muscle biopsy lysates (1 mg · ml-1) from pre and post sub-
ject-matched samples were loaded on parallel lanes at identical
protein titers (3 μg · μL-1) on polyacrylamide gels and elec-
trophoresed and blotted as previously described36. Alpha tubulin
served as housekeeping protein. Briefly, MuRF1 and MuRF2
mono/polyclonal antibodies (Abcam ab57865 and ab4125), and
a second poly MuRF-2 antibody (kindly gift of S. Labeit,
Mannheim, Germany) were used as previously described38 for
WB with human tissue. Anti-calpain 1 (poly-rabbit, #28258), -
calpain 2 (poly-rabbit, ab39165), and -calpastatin (poly-chicken,
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Figure 1. Dystrophin immunohistochemistry in bed rest muscle biopsies and fiber cross-sectional area (FCSA) determination in MTBR study
samples. A. Soleus and vastus lateralis cross-sections immunostained for dystrophin from 21-days mid-term (MTBR) study (upper panel), and
from the 2nd Berlin BedRest (BBR-2) study (lower panel) at bed rest start (CTR-pre) and end (CTR-post). Bars=75 μm (for all). B. Bar graphs
showing campaign-wise (1st and 2nd campaign) quantitative determination (% change FCSA, μm2 from baseline) in SOL and VL myofiber types
in the MTBR study groups (CTR vs NUTR). C. MTBR study FCSA data (pooled raw data) in both muscles, fiber types (type I and II) vs. study
groups. SOL=soleus; VL=vastus lateralis, ABL=average baseline; nd=not determined.
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ab16423) were from Abcam Inc. We used secondary alkaline-
phosphatase conjugated antibodies (swine-anti-rabbit, #D0306,
DACO; goat-anti-rabbit, Sc-2928, Santa Cruz Inc.). Reflexive
densities (RD) were measured in WB by densitometry scanning
(G-800, Quantity One™ Protein Analysis software, Biorad Inc.)
normalized to tubulin content (anti-alpha-tubulin, monoclonal,
#T6199, Sigma). Mean RD values (arbitrary units) from indi-
vidual CTR or NUTR groups were tested against average base-
line (ABL) values calculated from the pooled Pre values of
either groups (CTR-Pre plus NUTR-Pre).
Statistics 
Data are presented as mean ± standard deviation (S.D.), or
standard error of means (S.E.M.). The baseline data for the
first and second campaign were either analysed subject-
matched (pre vs. post) or pooled (group-wise), and differences
between baseline, 21 days bed rest (CTR) and 21 days bed rest
+ supplement (NUTR) were tested by paired Student´s t-test
(Sigma Plot 9.0 or SPSS 19.0). A repeated measures ANOVA
with muscle as within factor (SOL vs. VL) and between factor
condition (ABL, CTR, NUTR) was used. Differences were
considered significant at p<0.05. 
Results
Sarcolemma microstructure in myofibres 
Immunohistochemical appearance of dystrophin identified
typically “ring-like” immunopatterns in most of the cross-sec-
tioned and subject-matched CTR-post vs CTR-pre soleus and
vastus lateralis (VL) biopsy reflecting an intact outer mem-
brane with regular subsarcolemma microstructures present in
less atrophic MTBR myofibres after 3 weeks in bed rest (Fig-
ure 1A, upper panel). For comparison, irregular dystrophin im-
munopatterns are clearly evident in highly atrophic soleus
muscle fibres from a 8 weeks long-term bed rest (2nd Berlin
BedRest, BBR2)35 study suggestive for structural perturbations
in highly atrophic myofibres that however were absent from
the 3 weeks MTBR study samples (Figure 1A, lower panel).
Myofibre phenotype and size
We next documented changes in the myofibre cross-sec-
tional area (FCSA) in triple-immunostained transversely cut
myofibre profiles by individual quantitative analysis in SOL
and VL for each subject of the MTBR study (Figure 1B). We
found variable results showing within-group variability in all
muscle samples and type I or II myofibres from the CTR group
of 1st campaign participants (n=4, n=5) and significant changes
(reduced FCSA) only for myofibres I in SOL of 2nd campaign
participants (n=3, n=4) (Figure 1B). In VL muscle, there was
a change in FCSA of myofibre type I from the NUTR group
only from 2nd campaign participants (n=4) not seen in the
NUTR group from the 1st campaign (n=4). Such changes found
between campaigns were no longer observed after pooled data
analysis (Figure 1C). 
We then analysed the myofibre type distribution in SOL and
VL biopsies from the MTBR study using MyHC immunohis-
tochemistry for the two major MyHC subtypes, slow (type I)
and fast (type IIa, IIx). Hybrid myofibres (asterisks) were pos-
itive for both MyHC immunolabels (Figures 2A and 2B). In
SOL of CTR group we found a trend for a myofibre I to II tran-
sition as reflected by the presence of only a few hybrid fibres
(<2% vs normal baseline) in all subjects at the end of MTBR
(Figure 2C). In SOL and VL of the NUTR group, however, we
found an increase in hybrid fibre formation (>40% to 80% vs.
baseline) mainly in the 2nd campaign subjects reflecting ongo-
ing myofibre remodeling (Figure 2C). However, the pooled
data analysis given as pie graphs (Figure 2D) did not reveal
changes in hybrid fibre quantities between study groups ob-
served after campaign-wise analysis. 
Muscle total protein extracts
In general, global screening of relative muscle protein con-
tent from the MTBR biopsy samples revealed no significant
changes in the total amount of RIPA-buffer soluble proteins
between pre and post samples, except those found in VL from
CTR group if compared to average baseline suggesting the ho-
mogenous quality of the biopsy samples (Table 2). 
Soleus (SOL) Vastus lateralis (VL)
CTR (n=8) NUTR (n=10) CTR (n=8) NUTR (n=10)
Pre Post Pre Post Pre Post Pre Post
574.6 557.9 544.7 564.2 636.6 655.9 571.8 589.1
±24 ±23 ±17 ±19 ±20 ±25 ±13 ±12
P<0.627# P<0.465# P<0.567# P<0.358#
P<0.996* P<0.800* P<0.05* P<0.583*
Pre/Post values represent means (mg · ml-1 · g wet mass-1) ± SEM.
Significance at P<0.05; #ANOVA (within group) post vs. pre; *ANOVA (between groups) vs. average baseline (pre) of SOL and VL.
Table 2. Relative protein concentration (biopsy).
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Figure 2. Myosin-heavy-chain (MyHC) immunohistochemistry and quantitative myofibre type distribution analysis of MTBR study samples.
A. Control (CTR) group: Soleus (SOL, upper two panels) and Vastus lateralis (VL, lower two panels). B. Nutrition (NUTR) group: SOL and
VL (upper and lower two panels). Triple immunostaining of cross-sections (slow MyHC I [red] / fast MyHC II [green] / dystrophin [blue])
shown as individual (red-green-blue), and merged (red-green-blue-yellow) confocal images. Asterisks (*) denote hybrid fibres (slow/fast MyHC
co-immunolabel). Bar=200μm (left lower panel, for all). C. Quantification (% change vs pre) of 1st and 2nd campaign myofiber type distribution
based on MyHC I, MyHC IIa/IIx, and hybrid fiber immunopatterns (cf. A, B). D. Quantification (pie chart, pooled study data) of SOL (upper
panel) and VL (lower panel) muscle type I, type II or hybrid (h) myofibre distribution (given as %) determined by group-wise (CTR vs NUTR)
differential MyHC I/II/h immunopositive myofibre counts in histological cross-sections. P-values, see graph; nd=not determined.
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Biochemical analysis of MyHC protein isoforms
As expected the proportion of MyHC I proteins determined
by SDS-PAGE were larger in the soleus than the vastus lateralis
(p<0.001) vs. baseline (Figure 3). The relative proportion of
MyHC 1 (p<0.024) and MyHC IIx (p<0.021) was variably
changed (higher or lower vs baseline) in both muscles particu-
larly in the 2nd campaign NUTR group subjects (Figure 3B).
Pooled data analysis (Figure 3C) showed changes in both MyHC
IIa (p<0.028) and MyHC IIx (p<0.004), but not in MyHC I
(p<0.001). Though differences in muscle were obvious (as re-
flection of the known myofibre I to II transition) a statistical dif-
ference between the two bed rest groups (CTR or NUTR) was
not found by pooled group analysis with respect to MyHC iso-
form composition in soleus or vastus lateralis (Figure 3C).
Proteasome-based protein breakdown markers (MuRF1 and
MuRF2)
No changes in MuRF1 (not shown) or MuRF2 immunohis-
tochemical expression levels were present in the myofibres
from the 21 day MTBR study groups (Figure 4A, upper panel).
For comparison (Figure 4A. lower panel), a strong cytosolic
MuRF2 immunohistochemical detection pattern is found in at-
Figure 3. Relative myosin heavy chain (MyHC I, IIa, IIx) isoform composition in MTBR study samples. A. Silver-stained SDS-PAGE of 1st
and 2nd campaign samples (overview). B. Bar graphs showing campaign-wise % differences (open vs. black columns) in MyHC I (p<0.024)
and MyHC IIx (p<0.021) composition between muscle types (VL vs. SOL). C. Bar graphs (pooled study data) of muscle-specific MyHC isoform
composition (VL vs. SOL) in CTR (grey bars) vs. NUTR group (black bars) and average baseline (open bars). ABL=average baseline.
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Figure 4. MuRF-related proteolysis markers in human soleus biopsy from a medium-term (21d MTBR) vs. long-term bed rest study (60d BBR-2)
at start (pre) and end (post). A. MuRF2 immunofluorescence, upper panel (CTR-pre vs CTR-post and NUTR-post), lower panel (BBR2 study,
CTR-pre vs. post, two examples). CTR = control group, NUTR=nutrition group. Bars=75 μm. B and C. MTBR study: Quantitative subject-
matched (Pre vs. Post sample lanes, 48 kD) immunoblot analysis for MuRF1 (B), and MuRF2 (C) in pre vs. post SOL and VL (grey and black
columns) vs. average baseline (open bars). SOL=soleus, VL=vastus lateralis, ABL=average baseline; RD=reflexive density per square milimeters
(RD · mm-1). P-values, see graph.
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rophic SOL myofibres of a 60 day BBR2 study biopsy (Figure
4A, lower panel). These immunohistochemical results were
largely supported by the biochemical MuRF1 and MuRF2 im-
munoblot analysis (Figure 4B and C) by using the same anti-
MuRF1 and anti-MuRF2 antibodies that both showed little
proteolysis marker changes in either muscle (SOL, VL) or bed
rest conditions. 
Calpain-based protein breakdown markers (Calpain 1, 
Calpain 3, and Calpastatin)
Immunoblot analysis of subject-matched MTBR soleus
lysates were performed using calcium-dependent cystein pro-
tease markers, anti-calpain 1 (Figure 5A), -calpain 3 (Figure
5B), and endogenous calpain-specific inhibitor protein marker
anti-calpastatin (Figure 5C). Quantitative analysis did not
show significant changes between groups (0.95<p>0.42) com-
pared to average baseline (ABL) values in each CTR or NUTR
group (Figure 5A-C).
Discussion 
Bed rest is an established experimental model to simulate
the physiological effects of disuse on the human organism39
and represents a key model for studying muscle structural and
physiological adaptation to deconditioning that may occur in
various clinical settings including critical care40, but also fol-
lowing microgravity exposure in Space41-43. Apart from often
strenuous and high intensity exercise prescriptions that may
not always be well tolerated in muscle during periods of dis-
use, alternative countermeasure protocols including nutritional
supplementation could be a reasonable and feasible approach
to a reduction of muscle wasting in prolonged inactivity in bed
rest, critical illness or spaceflight19. The present MTBR study
was designed to study the effects of a promising new combi-
nation of whey protein plus bicarbonate as nutritional coun-
termeasure to impede disuse-induced skeletal muscle atrophy
following 3 weeks of bed rest. 
In the present study, we found no significant changes in
muscle protein breakdown levels in bed rest as measured in-
directly by calpain 1, calpain 3, calpastatin, MuRF1 or MuRF2
antigen markers either used for immunohistochemistry or in
immunoblots. Recent findings suggested that calpains acti-
vated by PGC1α44 for example via elevated cytosolic calcium
in disused mouse soleus45 may act “upstream” of the UPP by
activating proteasome-dependent proteolysis and inhibiting the
Akt/mTOR signaling pathway of protein synthesis46-47. The
lack in calpain/MuRF-related proteolysis marker changes
found in the present MTBR study in humans coincides with
the proposed idea that MPB may not always contribute sub-
stantially to human skeletal muscle in disuse39. Perhaps, alter-
native pathways of muscle protein degradation (e.g., via
lysosomal cathepsin proteases, SUMOylation, glucuronida-
tion, or autophagy) may equally be at work following disuse
to be further investigated in forthcoming bed rest studies.
Based on the present outcome and on recent reports either
variable protein turn-over, subject variability or experimental
design of studies on healthy humans are even more critical de-
terminants48 particularly under various periods of disuse. Pro-
tein turn-over appears to vary during the time course of
Figure 5. Calpain-related proteolysis markers in MTBR study biopsies (SOL). Upper panel: representative subject-matched Pre vs. Post sample
lanes of the immunoblot analysis for calpain 1 (A), calpain 3 (B), and calpastatin inhibitor (C). Lower panel: bar graphs showing quantitative
immunoblot analysis between pre and post study groups (grey and black columns) compared to average baseline (ABL, open bars), RD=reflexive
density per square milimeters (RD · mm2). P-values, see graph.
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disuse49 or may also be affected by the timing of protein ad-
ministration during or after a period of disuse50-51. Short-term
muscle disuse (1 to 7 days) resulted in more ubiquitinated mus-
cle proteins52 and early acute atrophy effects were frequently
reported only at mRNA and molecular signaling pathway level
by altered MuRF1/MAFbx transcript levels following a few
days of human muscle disuse after cast immobilization53. The
rise in protein breakdown may also imbalance protein synthe-
sis that may both converge in ongoing muscle atrophy thus
mediating the rate of muscle atrophy in short (<10 days) or
medium-term duration (>10 days) disuse periods54. Changes
in expression levels of MuRF-mRNA were indeed recently
found in cast immobilized human skeletal muscle after short
disuse (5 days)52 and in knee braced disuse in young or old
healthy men (4 days)51. These changes were also associated
with impaired single fibre contractile function53, data suggest-
ing initial molecular atrophy changes to occur prior to onset
of structural atrophy (reduced myofibre size, myofibrillar pro-
tein wasting) of disused human skeletal muscle. It is suggested
that ubiquitin protein conjugates and related proteolysis mark-
ers (MuRFs, atrogins) acutely upregulated within the first days
of immobilization and may return back to steady state levels
within two weeks39,51. If we consider a 20 days estimated half-
life time span of human muscle proteins determined from iso-
lated fibre bundles53 one in vivo “completed” muscle protein
turnover cycle would have been terminated at least in the range
of about two to three weeks depending on normal activity lev-
els or disuse in bed rest. Even more, both hypocaloric and hy-
percaloric nutrition may affect MPB as previously shown in
bed rest55-56 suggesting isocaloric (normocaloric) nutritional
intervention (this study) as a standardized requirement for
studying protein balance in human nutritional intervention bed
rest studies. Further time course studies are necessary in order
to unequivocally address the still puzzling human muscle pro-
tein turnover and wasting and its tightly linked moderation by
specific protein supplementation, for example, testing them in
various durations of bed rest.
Physical inactivity alone may account for a recently termed
“metabolic inflexibility” including insulin resistance observed
after muscle inactivity such as in bed rest57. A disturbed regular
amino acid/protein uptake during feeding known as “anabolic
resistance” suggested adaptive depression rather than increases
of muscle proteolysis as a critical mechanism to impaired
homeostasis in regular muscle mass in disuse58. It is also sug-
gest that yet unknown signaling pathways inherent to muscle
sensing a “muscle-full state” might result in anabolic resist-
ance to muscle protein synthesis59. 
At first sight, we may think that the obvious lack of any
structural myofiber atrophy (size or type changes) and little if
any signs of protein degradation (via indirect immunohisto-
chemical and biochemical protein breakdown markers) would
be the result of BR and/or the specified alkaline protein sup-
plement administered during BR. Unlike previously shown in
60 or 90 days long-term BR35-36, significant structural atrophy
(reduced myofibre FCSA profiles demarcated by dystrophin
marker) was not really observed in the present medium-term
BR study with the post biopsy sampled at BR+19 (i.e., 19 days
MTBR study). As part of a multiglycoprotein subsarcolemmal
scaffold complex (DGC) dystrophin is considered a key func-
tional protein necessary for mechanical linking of intramyocel-
lular contractile forces via actin to extracellular matrix proteins
such as laminins60. Intact dystrophin scaffold is thus crucial
for membrane stability in normally active skeletal muscle and
in force transduction61. We think that altered dystrophin im-
munopatterns seen in the myofibres after chronic disuse (e.g.,
8 weeks, Berlin BedRest Study, BBR-2)35 are histomorpholog-
ical signatures of progressive structural atrophy (e.g., myofib-
rillar protein wasting) in shriveled myofibres possibly due to
an “oversized” outer membrane envelopment with altered me-
chanical properties) that, however, was not seen after only 3
weeks of disuse in the present MTBR study. 
A slow-to-fast myofibre type transition is a well-known
phenomenon typically found after longer periods of human
skeletal muscle disuse and also found in the present 21 days
bed rest study. Nevertheless, even after 5 weeks of disuse
many fibres were still observed in a transitory state (expressing
both MyHC I and II proteins) compared to much earlier de-
tectable MyHC mRNA and gene transcriptional changes found
in the human vastus lateralis prior to MyHC protein expression
with an apparent mismatch found in bed rest62.
The present data analysis revealed some peculiar results re-
lated to myofibre phenotype distribution in skeletal muscle
from both MTBR campaigns subjects who, however, revealed
within-group variations. Increased hybrid fibre formation seen
in the MTBR study likely reflects ongoing tissue remodeling
with yet incompleted fibre transition (slow I-to-fast II) partic-
ularly in the SOL of the 2nd MTBR campaign subjects. In VL,
however, the 1st campaign NUTR group showed a trend to de-
layed myofibre transition, but this effect was found significant
only in the 2nd MTBR campaign NUTR group. A three months
interim phase between the 1st and 2nd MTBR campaign is usu-
ally considered sufficient for the randomized cross-over design
study34. Due to the present findings, however, a straightforward
explanation for such differences might be that the interim
phase of three month probably was too short to wash-out all
campaign effects. In other words, the presently accepted notion
of a simple “reset” of structural and functional or even molec-
ular properties inherent to skeletal muscle tissue back to base-
line levels, for example, in cross-over design BR study groups
with their skeletal muscles challenged by immobilization and
re-mobilization or vice versa should be critically assessed for
future BR studies.
Gain or maintenance in muscle mass is known to be likely
controlled by activity levels63-64. The aim of the study was to
clarify whether or not a protein-based nutritional intervention
on its own may be effective as a reliable anti-catabolic strategy
to overcome disuse-induced atrophy in healthy subjects. Our
results indicate that this was not the case. A recent study in
older (50±8 years) exercised and young (21±8 years) untrained
humans consuming protein supplements after aerobic exercise
did not increase rates of mixed muscle protein synthesis over
6 weeks despite the MPS was higher than in the younger
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sedentary group65. Another study with young untrained men
showed that whey protein initiates protein translation in exer-
cised skeletal muscle via the mTOR-dependent signaling path-
way66. The absence of mechanical loading during the bed rest
period and/or even a variable activity status of the participants
before study start or even during the interim period between
campaigns might account for the unexpected outcome of the
MTBR nutrition-only study that showed little if any changes
in the structural myofibre properties.
We conclude that alkaline whey protein supplementation
showed only marginal changes at least on structural myofibre
properties with possible delayed hybrid fibre transition in some
but not all subjects throughout the bed rest periods that, in turn,
is possibly also due to some unexpected campaign differences
(carry-over effects) explored in the present study. The present
study also revealed no major changes in key proteolysis mark-
ers in biopsy material from two different reference skeletal
muscles suggesting little if any proteolysis to occur above con-
stitutive protein turn-over in disused human skeletal muscle
after three weeks of bed rest. Based on the present study out-
come we suggest that future studies aimed at investigating an-
abolic compounds in disuse may require longer interim phases
between campaigns, a strict control regarding habitual activity
profiles, including subject monitoring also during the interim
phase of a cross-over study design, in addition to monitoring
ambulatory period activity levels34. Countermeasure trials
using whey proteins to moderate disuse atrophy should be
tested in longer duration bed rest disuse (>3 weeks) probably
combined with mechanical muscle loading as additional ana-
bolic trigger. The study findings may have wider implications
for therapeutic potential studies of sustained protein wasting
after periods of inactivity, cachexia or sarcopenia. 
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